Founded in Queensbury in 1988, AngioDynamics develops and manufactures medical devices for minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. Its global portfolio includes technologies such as the NanoKnife system for electrical tumor ablation and the Auryon system for peripheral artery disease, supported by manufacturing facilities in New York and worldwide operations. The company is a NASDAQ-listed public company serving physicians through direct sales and distribution partners.